Stockreport

Olema Oncology to Participate in Morgan Stanley 22nd Annual Global Healthcare Conference

Olema Pharmaceuticals, Inc.  (OLMA) 
PDF SAN FRANCISCO, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focu [Read more]